
Is Beam Therapeutics Inc (NASDAQ: BEAM) Stock Good For Medium-Term Investing?
Beam Therapeutics Inc (NASDAQ:BEAM) traded at $16.19 at close of the session on Monday, June 02 and made an upward move of 2.27% on its previous day’s price. Beam Therapeutics Inc has a market cap of $1.63 billion and is expected to release its quarterly